Effect of Shiga toxin 2 on water and ion transport in human colon in vitro

Digestive Diseases and Sciences

Volumn 45, Issue 3, 2000, Pages 480-486

  Fiorito, Paula ^a   Burgos, Juan M ^a   Fernandez Miyakawa, Mariano ^a   Rivas, Marta ^a   Chillemi, German ^a   Berkowski, Dario ^a   Zotta, Elsa ^a   Silberstein, Claudia ^a   Ibarra, Cristina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Escherichia coli; Hemolytic uremic syndrome; Human colon; Ion transport; Shiga toxin; Water transport

Indexed keywords

SHIGA TOXIN; UNCLASSIFIED DRUG; VEROTOXIN 2;

ARTICLE; CELL SPECIFICITY; COLITIS; COLON ABSORPTION; COLON MUCOSA; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HUMAN TISSUE; ION TRANSPORT; PRIORITY JOURNAL; TOXIN ANALYSIS; WATER ABSORPTION; WATER FLOW;

BACTERIAL TOXINS; COLON; ENTEROTOXINS; ESCHERICHIA COLI; HUMANS; INTESTINAL MUCOSA; ION TRANSPORT; SHIGA TOXINS; WATER;

EID: 0034023073     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005480720832     Document Type: Article

References (26)

1. 1. Griffin PM, Tauxe RV: The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 13:60-98, 1991
2. 2. Rivas M, Balbi L, Milliwebsky E, Garcia B, Tous M, Leardini N, Prieto M, Chillemi G, De Principi M: Síndrome urémico hemolítico en niños de Mendoza, Argentina: Su asociación con la infección por Escherichia coli productor de toxina Shiga. Medicina 58:1-7, 1998
3. 3. Richardson SE, Karmali MA, Becker LE, Smith CR: The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli. Hum Pathol 19:1102-1108, 1988
4. 4. Sandvig K, Van Deurs B: Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin. Physiol Rev 76:949-966, 1996
5. 5. Acheson DWK, Moore R, De Breucker S, Lincicome L, Jacewicz M, Skutelsky E, Keusch GT: Translocation of Shiga toxin across polarized intestinal cells in tissue culture. Infect Immun 64:3294-3300, 1996
6. 6. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, Hebert RJ, Olcott ES, Johnson LM, Hargrett NT, Blake PA, Cohen ML: Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308:681-685, 1983
7. 7. Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, Lewis JH, Blake PA: Illnesses associated with Escherichia coli O157:H7 infections. Ann Intern Med 109:705-712, 1988
8. 8. Kandel G, Donohue-Rolfe A, Donowitz M, Keusch GT: Pathogenesis of shigella diarrhea. XVI. Selective targeting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal eletrolyte transport. J Clin Invest 84:1509-1517, 1989
9. 9. Keenan KP, Sharpnack DD, Collins H, Formal SB, O'Brien AD: Morphological evaluation of the effects of Shiga toxin and Escherichia coli Shiga-like toxin on the rabbit intestine. Am J Pathol 125:69-80, 1986
10. 10. Pai CH, Kelly JK, Meyers GL: Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect Immun 51:16-23, 1986
11. 11. Kelly J, Oryshak A, Wenetsek M, Grabiec J, Handy S: The colonic pathology of Escherichia coli O157:H7 infection. Am J Surg Pathol 14:87-92, 1990
12. 12. O'Brien AD, Holmes RK: Shiga and shiga-like toxins. Microbiol Rev 51:206-220, 1987
13. 13. Karmali MA, Petric M, Lim C, Cheung R, Arbur GS: The association between Hemolytic Uremic Syndrome and infection by verotoxin producing Escherichia coli. J Infect Dis 151:775-782, 1985
14. 14. Mena MF, Tous M, Miliwebsky E, Chillemi G, Rivas M: Differential kinetic patterns for shiga toxin production by Escherichia coli. Rev Arg Microbiol 29:167-175, 1997
15. 15. Burgos JM, Pérez JL, García L, González GS, Benítez JA, Galindo F, Silberstein C, Ibarra C: Diarrheagenicity evaluation of attenuated Vibrio cholerae O1 and O139 strains in the human intestine ex vivo. Vaccine 17:949-956, 1999
16. 16. Dorr RA, Kierbel A, Vera J, Parisi M: A new data-acquisition system for the measurement of the net water flux across epithelia. Comput Methods Program Biomed 53:9-14, 1997
17. 17. Escobar E, Ibarra C, Todisco E, Parisi M: Water and ion handling in the rat cecum. Am J Physiol 259:G786-G791, 1990
18. 3 . Biochim Biophys Acta 1027:257-263, 1990
19. 19. Ibarra C, Kierbel A, Capurro C, Rivas M, Fernandez-Marty A, Galindo F, Parisi M: Water permeability properties of the human small intestine in vitro: Effects of Escherichia coli heat-stable enterotoxin. Acta Physiol Pharmacol Ther Latinoam 46:159-167, 1986
20. 20. Wills NK, Alles WP, Sandle GI, Binder HJ: Apical membrane properties and amiloride binding kinetics of the human descending colon. Am J Physiol 247:G749-G757, 1984
21. 21. Sellin JH, De Soignie R: Ion transport in human colon in vitro. Gastroenterology 93:441-448, 1987
22. 22. Singh SK, Binder HJ, Boron WF, Geibel JP: Fluid absorption in isolated perfused colonic crypts. J Clin Invest 96:2373-2379, 1995
23. 23. Tesh VL, O'Brien AD: The pathogenic mechanisms of Shiga-toxin and the Shiga-like toxin. Mol Microbiol 5:1817-1822, 1991
24. 24. Jacewicz M, Keusch GT: Pathogenesis of Shigella diarrhea. VIII. Evidence for a translocation step in the cytotoxic action of Shiga toxin. J Infect Dis 148:844-854, 1983
25. 25. Sandwig K, Olsnes JE, Brown OW, Petersen B, van Deurs B: Endocytosis from coated pits of Shiga toxin: A glycolipid-binding protein from Shigella dysenteriae 1. J Cell Biol 108:1331-1343, 1989
26. 26. Tesh VL: Virulence of enterohemorrhagic Escherichia coli: Role of molecular crosstalk. Trends Microbiol 6:228-233, 1998